探讨在新生儿肺炎治疗过程中采用普米克令舒联合氨溴索雾化方法对其的治疗效果。方法:选取本科2012年收治的150例新生儿肺炎患者,按照随机数字表法将其分为普米克令舒治疗组、氨溴索雾化治疗组和普米克令舒联合氨溴索雾化治疗组,每组50例患儿,观察比较三组对新生儿肺炎的治疗效果。结果:普米克令舒联合氨溴索雾化治疗组有效率为94%,明显高于其他两组,且普米克令舒联合氨溴索雾化治疗组的住院时间、肺部湿啰音消失时间、停氧时间等均明显短于其他两组,比较差异均有统计学意义(P0.05)。结论:普米克令舒联合氨溴索雾化治疗组对治疗新生儿肺炎有着明显的治疗效果,尤其对吸入性肺炎以及感染性肺炎均有良好的治疗效果。

Objective:To explore the use of neonatal pneumonia pulmicort in treatment process make comfortable and ambroxol atomization method for its therapeutic effect.Method:One hundred and fifty neonatal pneumonia patients were selected in 2012 in our department,they were randomly divided into the pulmicort respules group,the ambroxol group and the pulmicort combined ambroxol atomization treatment group,50 cases in each group,treatment effects were observed and compared among the three groups.Result:The efficiency of pulmicort combined ambroxol atomization treatment group was 94%,it was significantly higher than the other two groups,and the relevant clinical indexes of visible pulmicort combined ambroxol treatment group for hospitalization time,lung wet rales disappearance time,stop oxygen time were significantly shorter than the other two groups,the difference were statistically significant(P<0.05).Conclusion:Pulmicort combined ambroxol aerosol treatment group has obvious therapeutic effect o

目的：探讨普米克令舒和可必特雾化吸入治疗哮喘性支气管炎的临床效果。方法：选取2012年10月～2013年10月在我院治疗的哮喘性支气管炎患者96例，随机分组，观察组48例采用普米克令舒联合可必特雾化吸入治疗，对照组单纯采用普米克令舒雾化吸入治疗，观察疗效并对比分析。结果：观察组的总有效率为97.8%，对照组总有效率为71.7%，差异显著（P＜0.05），具有统计学意义。对比治疗期间两组患者临床症状好转时间，观察组优于对照组，指标差异显著（P＜0.05），具有统计学意义。结论：临床治疗哮喘性支气管炎采用普米克令舒联合可必特雾化吸入治疗，具有见效快、效率高的优势。

Objective: To investigate Pulmicort and Combivent inhalation treatment of asthma, bronchitis clinical results.Methods:From 2012 October ~2013 October in our hospital treatment of asthmatic bronchitis patients 96 cases, randomly grouping, the observation group 48 cases used pulmicort respules combined with combivent inhalation therapy, the control group were treated with pulmicort aerosol inhalation in treatment, the therapeutic effects were observed and comparative analysis.Results:The total effective observation group was 97.8% in the control group, the total effective rate was 71.7%,the difference was significant (P<0.05), with statistical significance.During the two groups of patients comparing clinical symptoms improved time,the observation group than the control group,the indexes were significantly different (P<0.05),with statistical significance.Conclusion:The clinical treatment of asthma, bronchitis using Pulmicort joint Combivent inhalation therapy, with quick, high e

分析雾化吸入普米克令舒和硫酸沙丁胺醇在儿童支气管哮喘中的应用。方法:选择支气管哮喘儿童64例,分析其初步情况,将患儿随机分成观察组和对照组,对照组给予常规哮喘治疗,而观察组加用普米克令舒和硫酸沙丁胺醇雾化吸入。两组进行疗效对比。结果:治疗后,治疗组无论在治疗时间还是在疗效上更优于对照组。结论:哮喘儿童应用普米克令舒和硫酸沙丁胺醇雾化吸入起效快,疗效好,可有效改善症状体征和肺功能。

Objective:To analyze the application of atomization inhalation pulmicort respulas and salbutamol sulfate in childhood bronchial asthma.Methods:64 children with bronchial asthma were selected.The initial condition was analyzed.They were randomly divided into the observation group and the control group.The control group were given the conventional treatment of asthma.The observation group were treated with pulmicort respulas and salbutamol sulfate atomization inhalation.The curative effects of two groups were compared.Results:After treatment,the treatment time and the urative effect of the treatment group were better than those of the control group.Conclusion:Application of pulmicort respulas and salbutamol sulfate atomization inhalation in children with asthma has quick and good curative effect.It can effectively improve the symptoms,signs and pulmonary function.

目的：观察沐舒坦联合普米克令舒雾化吸入在肺部手术后的临床疗效。方法将120例肺部手术后的患者随机分为沐舒坦联合普米克令舒氧气雾化吸入组（试验组）60例和对照组60例（超声雾化吸入法）进行研究。结果试验组在效果、血气分析的显著改变及肺功能的显著改变明显优于对照组（P〈0.05），试验组总有效率为96.7%，对照组总有效率为79.8%，两组有显著性差异（P〈0.05）。结论沐舒坦联合普米克令舒雾化吸入在肺部手术后疗效确切，值得临床推广。

Objective To observe the clinical therapeutic effect of spray inhalation with mucosolvan and Pulmicort in After Lung Surgery. Methods 120 cases were divided into two groups, atomizing inhalation of Pulmicort and mucosolvan(n=60)and ultrasonic at-omizing inhalation (n=60). Results such Efficacy and Blood gas analysis results in a significant and change Significant changes in lung function in treatmentgroup was superior to those of the control group significantly. The effect of treatment group was better than that of the controlgroup(P<0.05).There was staticaldifference between two groups(P<0.05).Conclusion Themethod of atomizing inhala-tion of Pulmicort andmucosolvan has an exact effecton After Lung Surgery and has a certain value for clinicalgeneral-ization.

观察老年非小细胞肺癌手术前后应用普米克令舒、沐舒坦雾化吸入对临床指标的影响,进一步探讨大剂量普米克令舒雾化吸入的临床疗效。方法:将90例接受开胸手术的老年非小细胞肺癌患者随机分为3组,在常规治疗基础上,于术前3 d和术后3 d观察1组予生理盐水10 ml+沐舒坦30 mg+普米克令舒1 mg、观察2组予生理盐水10 ml+沐舒坦30 mg+普米克令舒2 mg、对照组予生理盐水10 ml+沐舒坦30 mg雾化吸入,每天3次。比较3组之间PaCO2、PaO2、SaO2、、痰量、痰液pH值、术后住院天数、平均术后带管天数、术后体温、白细胞计数、中性粒细胞绝对值和中性粒细胞百分比、术后并发症等指标。结果:3组之间上述指标中除SaO2差异无统计学意义外,其余指标差异均有统计学意义(P0.01)。与对照组比较,观察组临床指标明显改善,其中观察2组临床指标改善更显著。结论:老年非小细胞肺癌手术前后应用大剂量普米克令舒联合沐舒坦雾化吸入对减轻肺部炎症具有较好的效果。

Objective: To observe the affect on clinical indicators of Pulmicort combined with Mucosolvan atomizing inhalation before and after surgery in elderly patients with non-small cell lung cancer and to further explore the clinical efficacy of large dose Pulmicort aerosol inhalation .Methods:Ninety elderly patients with non-small cell lung cancer who underwent thoracotomy surgery were randomly divided into three groups and on the basis of routine treatment,the observation group 1 was given saline 10 ml+Mucosolvan 30 mg +Pulmicort 1 mg, the observation group 2 was given saline 10 ml +Mucosolvan 30 mg+Pulmicort 2 mg, the control group was given saline 10 ml+Mucosolvan 30 mg inhalation three times a day , at three days before and after surgery , PaCO2 ,PaO2 ,SaO2 , sputum volume , sputum pH value , postoperative hospital stay days , the average postoperative days with pipe , postoperative body temperature , white blood cell values , absolute neutrophil count and neutrophil percentage , postop